Nordhealth As Stock Five Year Return
| NORDH Stock | 43.00 6.00 16.22% |
Nordhealth AS fundamentals help investors to digest information that contributes to Nordhealth's financial success or failures. It also enables traders to predict the movement of Nordhealth Stock. The fundamental analysis module provides a way to measure Nordhealth's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nordhealth stock.
Nordhealth |
Nordhealth AS Company Five Year Return Analysis
Nordhealth's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, Nordhealth AS has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Health Information Services (which currently averages 0.0) industry. This indicator is about the same for all Norway stocks average (which is currently at 0.0).
Nordhealth Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nordhealth's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nordhealth could also be used in its relative valuation, which is a method of valuing Nordhealth by comparing valuation metrics of similar companies.Nordhealth is currently under evaluation in five year return category among its peers.
Nordhealth Fundamentals
| Return On Equity | -0.11 | |||
| Return On Asset | -0.0552 | |||
| Profit Margin | (0.43) % | |||
| Operating Margin | (0.37) % | |||
| Current Valuation | 1.21 B | |||
| Shares Outstanding | 45.19 M | |||
| Shares Owned By Institutions | 50.31 % | |||
| Price To Book | 1.53 X | |||
| Price To Sales | 60.29 X | |||
| Revenue | 20.3 M | |||
| Gross Profit | 6.67 M | |||
| EBITDA | (369 K) | |||
| Net Income | (4.73 M) | |||
| Total Debt | 25 K | |||
| Book Value Per Share | 1.28 X | |||
| Cash Flow From Operations | 5.57 M | |||
| Earnings Per Share | (1.05) X | |||
| Target Price | 28.0 | |||
| Number Of Employees | 400 | |||
| Market Capitalization | 1.73 B | |||
| Total Asset | 125.13 M | |||
| Net Asset | 125.13 M |
About Nordhealth Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nordhealth AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nordhealth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nordhealth AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Nordhealth Stock
Nordhealth financial ratios help investors to determine whether Nordhealth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nordhealth with respect to the benefits of owning Nordhealth security.